Abstract
A 15-year-old boy with refractory juvenile rheumatoid arthritis (JRA) underwent intense immunosuppressive therapy followed by purified blood CD34+ cell autografting. He had been taking prednisolone (PDN) daily or every other day combined with methotrexate once a week to control the disease for 7 years. He suffered from psychological complications and a very short stature due to the adverse effects of these drugs. CD34+ cells were purified in bulk from G-CSF-mobilized PBSC using an Isolex 300. After the administration of cyclophosphamide (200 mg/kg) and anti-lymphocyte globulin (45 mg/kg), 3.6 × 106/kg purified CD34+ cells were infused. his post-transplant course was uneventful except for herpes-zoster infection. he is now more than 1 year post transplant and has not taken any immunosuppressive medication. his rate of growth has increased (>10 cm/year) due to the effects of the cessation of PDN and the administration of recombinant human growth hormone (rGH), in contrast to the gain of 2 cm in the preceding 3 years with rGH treatment. Although the durability of this remission is unknown, intense immunosuppressive therapy followed by purified blood CD34+ cell autografting might be acceptable for adolescent patients with refractory JRA to achieve a drug-free period for physical and psychological maturation. Bone Marrow Transplantation (2001) 27, 333–336.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Peterson LS, Mason T, Nelson AM et al. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960–1993: is the epidemiology changing? Arthritis Rheum 1996 39: 1385–1390
Thompson SD, Grom AA, Bailey S et al. Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis J Rheumatol 1995 22: 1356–1364
Peterson LS, Mason T, Nelson AM et al. Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study Arthritis Rheum 1997 40: 2235–2240
Joske DJ . Autologous bone-marrow transplantation for rheumatoid arthritis Lancet 1997 350: 337–338
Burt RK, Traynor AE, Pope R et al. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation Blood 1998 92: 3505–3514
Tyndall A, Fassas A, Passweg J et al. Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality Bone Marrow Transplant 1999 24: 729–734
Wulffraat N, Royen AV, Bierings M et al. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis Lancet 1999 353: 550–553
Snowden JA, Biggs JC, Milliken ST et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cells mobillisation in patients with severe active rheumatoid arthritis Bone Marrow Transplant 1998 22: 1035–1041
Kawano Y, Takaue Y, Watanabe T et al. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors Cancer Res 1999 59: 3321–3324
Takaue Y, Kawano Y, Abe T et al. Collection and transplantation of peripheral blood stem cells in very small children weighing 20 kg or less Blood 1995 86: 372–380
Polito C, Strano CG, Olivieri AN et al. Growth retardation in non-steroid treated juvenile rheumatoid arthritis Scand J Rheumatol 1997 26: 99–103
Saha MT, Verronen P, Laippala P et al. Growth of prepubertal children with juvenile chronic arthritis Acta Paediatr 1999 88: 724–728
Davies UM, Rooney M, Preece MA et al. Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone J Rheumatol 1994 21: 153–158
Rivkees SA, Danon M, Herrin J . Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure J Pediatr 1994 125: 322–325
Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 1997 19: 643–645
Traynor A, Burt RK . Haematopoietic stem cell transplantation for active systemic lupus erythematosus Rheumatology 1999 38: 767–772
Fouillard L, Gorin NC, Laporte JP et al. Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood Lupus 1999 8: 320–323
Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome Lupus 1998 7: 492–494
Marmont AM . Stem cell transplantation for severe autoimmune disease: progress and problems Haematologica 1998 83: 733–743
Acknowledgements
We thank Toshiko Yasuda for excellent technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakagawa, R., Kawano, Y., Yoshimura, E. et al. Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis. Bone Marrow Transplant 27, 333–336 (2001). https://doi.org/10.1038/sj.bmt.1702781
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702781
Keywords
This article is cited by
-
Autologous Hematopoietic Stem Cell Transplantation for 3 Patients with Severe Juvenile Rheumatoid Arthritis
International Journal of Hematology (2003)